Recombinant multi-species MRPL46 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MRPL46 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. [provided by RefSeq, Jul 2008]
The Alternative Names of target: MRPL46,Large ribosomal subunit protein mL46,39S ribosomal protein L46, mitochondrial (L46mt, MRP-L46), P2ECSL,mL46,LIECG2,P2ECSL,C15orf4

Target products collectionGo to MRPL46 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2606-Ab-1/ GM-Tg-hg-IP2606-Ab-2 Human MRPL46 protein Human
GM-Tg-rg-IP2606-Ab-1/ GM-Tg-rg-IP2606-Ab-2 Rat MRPL46 protein Rat
GM-Tg-mg-IP2606-Ab-1/ GM-Tg-mg-IP2606-Ab-2 Mouse MRPL46 protein Mouse
GM-Tg-cynog-IP2606-Ab-1/ GM-Tg-cynog-IP2606-Ab-2 Cynomolgus/Rhesus macaque MRPL46 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2606-Ab-1/ GM-Tg-felg-IP2606-Ab-2 Feline MRPL46 protein Feline
GM-Tg-cang-IP2606-Ab-1/ GM-Tg-cang-IP2606-Ab-2 Canine MRPL46 protein Canine
GM-Tg-bovg-IP2606-Ab-1/ GM-Tg-bovg-IP2606-Ab-2 Bovine MRPL46 protein Bovine
GM-Tg-equg-IP2606-Ab-1/ GM-Tg-equg-IP2606-Ab-2 Equine MRPL46 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2606-Ab-1/ GM-Tg-hg-IP2606-Ab-2; GM-Tg-rg-IP2606-Ab-1/ GM-Tg-rg-IP2606-Ab-2;
GM-Tg-mg-IP2606-Ab-1/ GM-Tg-mg-IP2606-Ab-2; GM-Tg-cynog-IP2606-Ab-1/ GM-Tg-cynog-IP2606-Ab-2;
GM-Tg-felg-IP2606-Ab-1/ GM-Tg-felg-IP2606-Ab-2; GM-Tg-cang-IP2606-Ab-1/ GM-Tg-cang-IP2606-Ab-2;
GM-Tg-bovg-IP2606-Ab-1/ GM-Tg-bovg-IP2606-Ab-2; GM-Tg-equg-IP2606-Ab-1/ GM-Tg-equg-IP2606-Ab-2
Products Name MRPL46 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MRPL46
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MRPL46 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.